Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Healthy Volunteer

98 clinical trials

133 products

1 drug

Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of REGN7508, a Monoclonal Antibody Against Factor XI, in Healthy Adult Subjects
Status: Recruiting, Estimated PCD: 2024-08-06
Product
REGN7508
Product
Matching Placebo
Product
BIIB122
Product
Rabeprazole
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Subcutaneous Doses of SAR444336 in Healthy Adult Participants
Status: Completed, Estimated PCD: 2023-12-12
Product
Placebo
Clinical trial
A Phase 1, Open-Label, Crossover Study to Assess the Potential for Gastric pH-Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants
Status: Active (not recruiting), Estimated PCD: 2024-05-07
Product
SAR444336
Clinical trial
A Phase 1 Randomized, Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With an Open-Label Target Occupancy Study of BIIB113 in Healthy Participants
Status: Completed, Estimated PCD: 2023-07-10
Product
Daridorexant
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Orally-administered Replication-competent Adenovirus Type-4 HIV Vaccine Regimens in Combination With an AIDSVAX® B/E Boost in Healthy, HIV-uninfected Adult Participants
Status: Terminated, Estimated PCD: 2017-02-01
Clinical trial
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Study to Investigate the Pharmacokinetics, Safety, and Tolerability After Single- and Multiple-Dose Daridorexant in Chinese Healthy Subjects
Status: Completed, Estimated PCD: 2023-12-24
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Racecadotril 100 mg Capsules and Reference Product (HIDRASEC®) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-09-17
Product
HIDRASEC®
Product
TNB-738
Clinical trial
A Phase 1, Double-blind, Single- and Multiple-ascending Dose Escalation Study of TNB-738, a Biparatopic Antibody Targeting CD38 in Healthy Volunteers
Status: Completed, Estimated PCD: 2023-05-04
Product
BIIB113
Product
11^C]BIO-1819578
Product
Racecadotril
Product
Lumacaftor/Ivacaftor
Product
Lumacaftor
Clinical trial
A Single-Dose, Bioequivalence and Food Effect Bioavailability Study in Healthy Volunteers Comparing the Commercial Lumacaftor 200 mg / Ivacaftor 125 mg Combination Film-Coated Tablet (Orkambi®) to the Lumacaftor 200 mg Film-Coated Tablet Formulation, and the Lumacaftor 200 mg Film-Coated Tablet Formulation in the Fasted to Fed State.
Status: Completed, Estimated PCD: 2023-12-18
Product
AT-527
Clinical trial
A Phase 1, Open-Label, Parallel-Group, Single-Dose Adaptive Study to Evaluate the Safety and Pharmacokinetics of AT-527 in Adult Subjects With Normal and Impaired Renal Function Sub-Study: Effects of Probenecid on the Pharmacokinetics of AT-527 in Healthy Adult Subjects
Status: Recruiting, Estimated PCD: 2024-04-23
Product
Ad4-mgag
Product
Ad4-EnvC150
Product
AIDSVAX B/E
Product
SPR720
Clinical trial
A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-05-31
Product
Empagliflozin
Product
JARDIANCE®
Product
AIDSVAX
Clinical trial
A Phase 1 Open-label, Non-randomized, Single Ascending Dose Escalation Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Ralinepag Extended Release (XR) Tablet Formulation In Healthy Chinese Subjects
Status: Completed, Estimated PCD: 2020-11-09
Clinical trial
A Phase 1, Single-center, Open-label Study to Assess the Intrapulmonary Pharmacokinetics of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.
Status: Completed, Estimated PCD: 2024-02-09
Product
Ralinepag
Clinical trial
An Open-label, Randomized, Multiple Dose, Two-way Crossover Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets and Reference Product (Xatral® XL 10 mg) in Healthy Thai Male Volunteers Under Fed Conditions
Status: Not yet recruiting, Estimated PCD: 2024-06-22
Product
Xatral XL
Product
Alfuzosin Hydrochloride
Product
TP-05
Product
BIIB800
Clinical trial
A Randomized, Double-Blind, Parallel-Group, Phase I Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 s.c. Compared to Actemra® in Healthy Male Participants
Status: Recruiting, Estimated PCD: 2024-11-30
Product
PF-06700841
Clinical trial
A PHASE 1, NON-RANDOMIZED, OPEN LABEL, SINGLE DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF PF-06700841 IN PARTICIPANTS WITH RENAL IMPAIRMENT AND IN HEALTHY PARTICIPANTS WITH NORMAL RENAL FUNCTION
Status: Completed, Estimated PCD: 2022-05-04
Product
Actemra
Product
Lumacaftor + Ivacaftor
Clinical trial
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Single-Center, Human Tick Kill Proof-of-Concept Study Evaluating the Safety, Tolerability, and Whole Blood Concentration of TP-05 (Lotilaner) in Healthy Volunteers
Status: Active (not recruiting), Estimated PCD: 2024-06-27
Product
[14C]-BIIB091
Clinical trial
A Phase 1, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Bemnifosbuvir (AT-527) in Adult Subjects With Normal and Impaired Hepatic Function
Status: Recruiting, Estimated PCD: 2024-03-29
Clinical trial
A Phase 1, Open-Label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of Single Oral Dose [14C]-BIIB091 in Healthy Male Participants
Status: Recruiting, Estimated PCD: 2024-05-13
Product
Bemnifosbuvir
Clinical trial
Mass Balance Study of [14C] ABBV-552 in Healthy Male Volunteers Following Single Oral Dose Administration
Status: Completed, Estimated PCD: 2024-04-19
Product
ABBV-552
Product
Placebo Comparator
Product
BIIB115
Clinical trial
A Randomized, Blinded, Placebo-Controlled, Phase 1 Single Ascending Dose Study in Healthy Adult Male Volunteers and an Open-Label Multiple Ascending Dose Study in Pediatric SMA Participants Previously Treated With Onasemnogene Abeparvovec (Zolgensma™) to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115
Status: Recruiting, Estimated PCD: 2027-05-26
Clinical trial
VP-VLY-686-1301: A Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy Volunteers
Status: Completed, Estimated PCD: 2021-09-24
Product
Tradipitant
Product
Nirsevimab
Clinical trial
A Phase IIIb Randomized Open-label Study of Nirsevimab (Versus no Intervention) in Preventing Hospitalizations Due to Respiratory Syncytial Virus in Infants (HARMONIE)
Status: Active (not recruiting), Estimated PCD: 2024-03-27
Product
High Dose TP-05
Product
MT-8554
Clinical trial
This is a Phase I, Randomized, Double-blind, Vehicle-controlled Study of QY101 Ointment in Chinese Healthy Subjects
Status: Completed, Estimated PCD: 2023-06-21
Clinical trial
Mass Balance Study of [14C] ABBV-903 in Healthy Male Subjects Following Single Oral Dose Administration
Status: Completed, Estimated PCD: 2023-10-13
Product
ABBV-903
Product
QY101
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Single-dose and Multiple-dose Study Evaluating the Pharmacokinetics and Safety of GFH312 in Healthy Chinese Subjects
Status: Completed, Estimated PCD: 2023-02-13
Product
AZD7442
Clinical trial
A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD7442 in Healthy Chinese Adults
Status: Completed, Estimated PCD: 2021-11-27
Product
KT-474/Placebo
Product
KT-474
Clinical trial
A Two-part, Phase I, Double-blind, Placebo- and Positive-controlled Crossover Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Subjects
Status: Completed, Estimated PCD: 2022-10-07
Product
Moxifloxacin
Product
Brensocatib
Product
EDG-5506
Product
Radiolabeled EDG-5506
Clinical trial
A Phase 1, Open-label Study in Healthy Male Subjects of the Absorption, Metabolism, Excretion, and Pharmacokinetics of EDG-5506 and an Absolute Bioavailability Study Using Radiolabeled EDG-5506
Status: Completed, Estimated PCD: 2023-04-06
Clinical trial
A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD CROSSOVER STUDY TO ESTIMATE THE EFFECT OF CARBAMAZEPINE ON THE PHARMACOKINETICS OF PF-07321332 BOOSTED WITH RITONAVIR IN HEALTHY PARTICIPANTS
Status: Completed, Estimated PCD: 2021-10-09
Product
Carbamazepine
Product
PF 07321332/Ritonavir
Product
Step 1: TS-142
Clinical trial
A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
Status: Completed, Estimated PCD: 2022-10-20
Product
PF-07321332/ritonavir
Product
GDC-0980
Clinical trial
An Open-Label, 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet
Status: Completed, Estimated PCD: 2011-02-03
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-951 in Healthy Subjects Following Intravenous Administration
Status: Completed, Estimated PCD: 2021-05-16
Product
TAK-951
Product
LT-002-158
Clinical trial
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-8554 After a Single Oral Dose to Healthy Male Subjects
Status: Completed, Estimated PCD: 2018-01-29
Product
[14C]Afuresertib
Product
Tinlarebant
Clinical trial
A Phase 1，Randomized, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers
Status: Not yet recruiting, Estimated PCD: 2024-11-10
Clinical trial
A Phase 1b, Open-Label, Parallel Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Tinlarebant in Healthy Volunteers Aged 50-85
Status: Completed, Estimated PCD: 2023-01-04
Clinical trial
In Vivo Absorption, Metabolism, Excretion (AME) Clinical Study of [14C]Afuresertib in Healthy Chinese Male Adults - Human Mass Balance and Biotransformation Study of [14C]Afuresertib
Status: Completed, Estimated PCD: 2022-10-21
Clinical trial
A Clinical Pharmacological Study of TS-142 in Non-Elderly and Elderly Healthy Participants (A Repeated-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Elderly and Non-Elderly Participants)
Status: Completed, Estimated PCD: 2019-11-30
Product
rabeprazole
Clinical trial
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-7117 After a Single Oral Dose to Healthy Male Subjects
Status: Completed, Estimated PCD: 2018-05-11
Product
MT-7117
Product
TS-142
Product
GFH312
Product
Aspirin
Clinical trial
A Parallel Group Study in Healthy Participants to Quantify Subclinical Gastrointestinal Blood Loss Following Administration of Aspirin Alone or Aspirin in Combination With Rivaroxaban
Status: Completed, Estimated PCD: 2023-04-06
Product
Rivaroxaban
Clinical trial
A Phase 1 Open-Label Drug-Drug Interaction Study Between ABBV-903 and Midazolam
Status: Completed, Estimated PCD: 2023-11-02
Product
Midazolam
Product
BION-1301
Clinical trial
BION-1301 - A Phase 1, Open-label, Single Subcutaneous Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Japanese Healthy Subjects
Status: Completed, Estimated PCD: 2022-12-16
Clinical trial
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants
Status: Completed, Estimated PCD: 2023-06-08
Clinical trial
A Randomized, Open-label, Parallel Design Study of the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products After Administration of Single Subcutaneous Doses
Status: Completed, Estimated PCD: 2015-01-17
Clinical trial
A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of MT-8554 at Two Dose Levels, MT-8554 Low Dose and MT-8554 High Dose, on the QT/QTc Interval in Healthy Adult Subjects
Status: Completed, Estimated PCD: 2018-10-19
Clinical trial
An Open Label, Multicentre, Randomised, 2-cohort, Sequential and Crossover Study to Assess the Relative Oral Bioavailability of MT-7117 Higher Content Tablets Versus MT-7117 Lower Content Tablets and the Pharmacokinetics of MT-7117 Under Various Gastric Conditions in Healthy Subjects
Status: Completed, Estimated PCD: 2018-12-22
Product
PPI
Clinical trial
A Phase I Study of TS-142 in Non-Elderly Healthy Participants (Repeated Doses) (A Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Non-Elderly Participants)
Status: Completed, Estimated PCD: 2016-10-08
Product
DNL919
Product
HIP1802
Product
HGP1705
Clinical trial
A Randomized, Open-label, Multiple Dose, Crossover Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
Status: Completed, Estimated PCD: 2021-11-03
Clinical trial
A Phase 1, Two-Part, Single-Center, Open-Label, Randomized, Cross-Over, Single Ascending Doses (SAD), Followed by a Multiple Ascending Doses (MAD) Safety and Pharmacokinetic Study of RT234 in Healthy Subjects
Status: Completed, Estimated PCD: 2019-12-04
Product
Vardenafil
Clinical trial
A Randomized, Open-label, Multiple Dose, Crossover Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
Status: Completed, Estimated PCD: 2020-10-30
Product
HIP2105
Product
RLD2104
Product
RT234 - Vardenafil inhalation powder
Clinical trial
A Randomized, Open-label, Single Dose, Crossover Study to Investigate the Effect of Food on the Pharmacokinetics and Pharmacodynamics of HIP1601 40 mg in Healthy Volunteers
Status: Completed, Estimated PCD: 2020-02-20
Product
HIP1601
Clinical trial
An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BIIB122 in Healthy Adult Japanese, Chinese, and Caucasian Participants
Status: Completed, Estimated PCD: 2022-09-07
Clinical trial
A Phase I Study of TS-142 in Non-Elderly Healthy Participants (Single Doses) (A Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Non-Elderly Participants)
Status: Completed, Estimated PCD: 2016-02-06
Clinical trial
Assessment of the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Volunteers
Status: Completed, Estimated PCD: 2023-06-20
Product
Dupilumab
Clinical trial
A Randomized, Open-Label, Single Dose, Cross-Over Study to Investigate the Bioequivalence of Three RO5424802 Test Formulations Versus a Reference Formulation Following Oral Administration in Healthy Subjects
Status: Completed, Estimated PCD: 2014-09-01
Product
Ro542-4802
Product
Ro542-4802/F03
Product
INDV-2000
Clinical trial
A Phase I Double-Blind, Placebo-Controlled Randomized Study to Assess Repeated Doses of INDV-2000 (C4X_3256) up to 28 Days in Healthy Volunteers, and an Open-Label Study of INDV-2000 up to 11 Days in Treatment Seeking Individuals With Opioid Use Disorder
Status: Completed, Estimated PCD: 2023-07-05
Product
Suboxone
Product
BIIB104
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants
Status: Completed, Estimated PCD: 2022-01-30
Clinical trial
A Phase 1a, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Overlapping Single and Multiple Ascending Dose Escalation Study of WP1122 to Establish Maximum Tolerated Dose and Evaluate Pharmacokinetics
Status: Completed, Estimated PCD: 2022-10-24
Product
WP1122
Clinical trial
Clinical Trial of Absorption, Metabolism and Excretion of [14C]-HEC585 in Chinese Adult Male Healthy Subjects
Status: Completed, Estimated PCD: 2022-08-14
Product
[14C]-HEC585
Product
Lumacaftor/Ivacaftor Film-Coated Tablet
Clinical trial
A Randomized, Open-Label, Parallel-Arm Study to Assess the Pharmacokinetic Comparability of 2 Fixed Subcutaneous Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous Dose in Healthy Volunteers
Status: Completed, Estimated PCD: 2022-07-27
Product
Aducanumab
Clinical trial
A Phase 1 First in Human, Single and Multiple Ascending Dose and Food Effect and Drug-Drug Interaction in Healthy Subjects to Evaluate the Safety, Tolerability and Assessment of Pharmacokinetics of ABBV-903
Status: Completed, Estimated PCD: 2023-10-23
Product
Itraconazole
Clinical trial
COVID-19: A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD CROSSOVER STUDY TO ESTIMATE THE EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS OF PF-07321332/RITONAVIR IN HEALTHY PARTICIPANTS
Status: Completed, Estimated PCD: 2021-09-30
Product
BMS-986369
Product
PF-06882961
Product
PF-06882961/PF-06865571
Product
PF-06882961 + PF-06865571
Clinical trial
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETIC INTERACTIONS BETWEEN PF-06882961 AND PF-06865571 IN HEALTHY ADULT PARTICIPANTS (PART A) AND OVERWEIGHT ADULTS OR ADULTS WITH OBESITY WHO ARE OTHERWISE HEALTHY (PART B)
Status: Completed, Estimated PCD: 2021-10-10
Product
GST-HG171/Ritonavir
Clinical trial
An Open Labe Study to Evaluate the Drug-Drug Interaction of Itraconazole With GST-HG171/Ritonavir in Healthy Adult Chinese Participants
Status: Completed, Estimated PCD: 2023-06-05
Clinical trial
A Phase 1, Two-part Study to Evaluate the Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of BMS-986369 and to Explore the Effect of Food the Bioavailability of BMS-986369 in Healthy Participants
Status: Completed, Estimated PCD: 2023-05-04
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers
Status: Completed, Estimated PCD: 2023-09-12
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Characteristics of DISC-3405 in Adult Healthy Male and Female Volunteers
Status: Recruiting, Estimated PCD: 2024-10-01
Product
DISC-3405
Product
IRL201104
Clinical trial
Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of CampETEC Hyperimmune Bovine Colostrum (HBC) for the Prevention of Campylobacter-Mediated Diarrheal Diseases
Status: Active (not recruiting), Estimated PCD: 2024-07-01
Product
CampETEC HBC
Product
ProMilk
Product
C. jejuni CG8421
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Amlodipine and Valsartan Tablets 10/160 mg and Reference Product (Exforge® 10/160 mg Tablets)
Status: Not yet recruiting, Estimated PCD: 2024-07-09
Product
Amlodipine/Valsartan
Product
Exforge
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Dabigatran Etexilate Capsules 150 mg and Reference Product (Pradaxa®) in Healthy Thai Volunteers Under Fasting Conditions and Under Pre-treatment With a Proton Pump Inhibitor
Status: Not yet recruiting, Estimated PCD: 2024-10-08
Product
Dabigatran Etexilate
Clinical trial
A Single Dose, Randomized, Open-label, Replicated Crossover Bioequivalence Study of Generic Simvastatin 40 mg Film-coated Tablets and Reference Product (ZOCOR®) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-08-17
Product
Simvastatin
Product
Zocor
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Diacerein 50 mg Capsule and Reference Product (ARTRODAR®) in Healthy Thai Volunteers Under Fed Conditions
Status: Not yet recruiting, Estimated PCD: 2024-08-03
Product
Diacerein
Clinical trial
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
Status: Completed, Estimated PCD: 2023-01-31
Product
Flucelvax
Product
Fluvirin
Product
Fluzone High Dose
Clinical trial
Measurement of Pulmonary Inflammation Using 18F-NOS Positron Emission Tomography (PET/CT) in E-cigarette Users
Status: Recruiting, Estimated PCD: 2024-10-23
Product
[18F]NOS
Clinical trial
A Single Dose, Randomized, Open-label, One-period Parallel Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product (Arava®) in Healthy Thai Male Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-04-23
Product
Leflunomide
Product
Arava
Clinical trial
Phase I Open-Label Study of Safety and Immunogenicity of AD4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Status: Recruiting, Estimated PCD: 2025-04-15
Product
Ad4-Env145NFL
Product
Ad4-Env150KN
Product
VRC-HIVRGP096-00-VP
Clinical trial
Mass Balance Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
Status: Recruiting, Estimated PCD: 2024-07-11
Product
ABBV-CLS-7262
Clinical trial
A Comparison Study of ADC189 Bioavailability Between Tablet and Granule in Healthy Chinese Adult Male Subjects, and the Safety and Pharmacokinetics of Ultra-high Dose ADC189
Status: Recruiting, Estimated PCD: 2024-07-03
Product
ADC189
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Acyclovir 800 mg Tablet and Reference Product (ZoviraxTM) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-02-15
Product
Acyclovir
Product
Zovirax 800 mg Tablet
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets and Reference Product (Xatral® XL 10 mg) in Healthy Thai Male Volunteers Under Fed Conditions
Status: Not yet recruiting, Estimated PCD: 2024-03-14
Clinical trial
Evaluation of in Vivo Neuroinflammation in Parkinson's Disease Using 18F-NOS Positron Emission Tomography (PET/CT)
Status: Active (not recruiting), Estimated PCD: 2025-08-01
Clinical trial
A Single Dose, Randomized, Open-label, Two-period, Two-sequence Crossover Bioequivalence Study of Generic Apixaban 5 mg Film-coated Tablets and Reference Product (ELIQUIS) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-09-14
Product
Apixaban
Clinical trial
Defining a Pharmacokinetic and Pharmacodynamic Model for Peripheral Analgesia After Intravenous Oxytocin
Status: Recruiting, Estimated PCD: 2024-12-01
Product
Oxytocin
Clinical trial
A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy Volunteers
Status: Not yet recruiting, Estimated PCD: 2028-01-31
Product
Tenofovir alafenamide
Product
Dolutegravir
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Celecoxib 200 mg Capsules and Reference Product (CELEBREXTM) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-09-27
Product
Celecoxib
Clinical trial
Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory
Status:
Product
0-15 Water
Clinical trial
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Status: Recruiting, Estimated PCD: 2025-01-01
Drug
Ketamine
Clinical trial
Evaluation of in Vivo Neuroinflammation in Alzheimer's Disease Using Novel Positron Emission Tomography (PET/CT) Imaging
Status: Recruiting, Estimated PCD: 2025-03-01
Product
[11C]PBR28
Clinical trial
Evaluation of D3 Receptor Occupancy Using [18F]FLUORTRIOPRIDE ([18F]FTP) PET/CT
Status: Active (not recruiting), Estimated PCD: 2024-06-01
Product
FTP PET
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Empagliflozin 25 mg Film-coated Tablets and Reference Product (JARDIANCE®) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-07-05
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Linagliptin 5 mg Film-coated Tablets (LINIPTIN) and Reference Product (Trajenta®) in Healthy Thai Volunteers Under Fasting Conditions
Status: Not yet recruiting, Estimated PCD: 2024-05-10
Product
Linagliptin
Product
Trajenta
Clinical trial
Phase II Trial Evaluating the Immunogenicity and Safety of BBIBP-CorV Vaccine in Adults in Guinea
Status: Active (not recruiting), Estimated PCD: 2023-08-03
Product
BBIBP-CorV
Clinical trial
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT and Reference Product (Galvus Met®) in Healthy Thai Volunteers Under Fed Conditions
Status: Not yet recruiting, Estimated PCD: 2024-05-25
Product
Vildagliptin and Metformin Hydrochloride
Clinical trial
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population
Status: Recruiting, Estimated PCD: 2024-07-01
Product
GS1-144
Clinical trial
A Phase 1, Open-Label, 2-Part, Single Dose, Crossover Study to Examine the Effect of Food and Cobicistat Administration on the Pharmacokinetics and Safety of Plixorafenib in Healthy Participants.
Status: Recruiting, Estimated PCD: 2024-10-31
Product
Plixorafenib
Product
Cobicistat
Clinical trial
A Phase 1, Open-Label Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults
Status: Not yet recruiting, Estimated PCD: 2025-05-19
Product
[89Zr]Zr-DFO-BIIB080
Product
BIIB080
Clinical trial
A Phase 1, Randomized, Double-Blind Study to Compare the Effect of Omadacycline PO Versus Moxifloxacin PO on the Gut Microbiota in Healthy Adult Volunteers
Status: Recruiting, Estimated PCD: 2024-07-30
Product
Omadacycline
Clinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SGB-9768 in Healthy Volunteers
Status: Not yet recruiting, Estimated PCD: 2025-05-03
Product
SGB-9768